Drug Shortage Report for PENICILLIN G SODIUM FOR INJECTION, USP

Last updated on 2020-02-13 History
Report ID 1772
Drug Identification Number 01930680
Brand name PENICILLIN G SODIUM FOR INJECTION, USP
Common or Proper name PENICILLIN G SODIUM
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) PENICILLIN G SODIUM
Strength(s) 10000000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10
ATC code J01CE
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-01-25
Estimated end date 2022-12-31
Actual end date
Shortage status Actual shortage
Updated date 2020-02-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-13 English Compare
v2 2017-03-13 French Compare
v3 2017-10-10 English Compare
v4 2017-10-10 French Compare
v5 2020-02-13 English Compare
v6 2020-02-13 English Compare
v7 2020-02-13 French Compare

Showing 1 to 7 of 7